XML 51 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Income Taxes
The components of the Company's loss before income taxes for the years ended December 31, 2024, 2023, and 2022 were as follows:
Year Ended December 31,
202420232022
(in thousands)
Domestic$(125,307)$(210,547)$(219,586)
Foreign54,436 32,685 28,853 
Total loss before income taxes$(70,871)$(177,862)$(190,733)
Schedule of Provision for (Benefit From) Income Taxes
The components of the Company's provision for (benefit from) income taxes for the years ended December 31, 2024, 2023, and 2022 were as follows:
Year Ended December 31,
202420232022
(in thousands)
Current expense:
Federal$1,681 $513 $332 
State142 324 
Foreign3,995 2,986 2,455 
Total current provision for income taxes$5,818 $3,823 $2,788 
Deferred expense (benefit):
Federal(1,205)— (1,124)
State(235)— (573)
Foreign3,551 2,264 1,557 
Total deferred provision for (benefit from) income taxes$2,111 $2,264 $(140)
Total provision for income taxes
$7,929 $6,087 $2,648 
Schedule of Reconciliation of U.S. Federal Statutory Rate to Effective Tax Rate
A reconciliation of the U.S. federal statutory rate to the Company's effective tax rate is as follows:
Year Ended December 31,
202420232022
Expected benefit at U.S. federal statutory rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefits0.1 (0.1)0.2 
Foreign income or losses taxed at different rates5.9 1.0 1.1 
Stock-based compensation60.8 12.4 18.7 
Non-deductible compensation
(9.4)(0.9)— 
Change in valuation allowance(84.8)(30.6)(41.2)
Withholding taxes(2.3)(0.3)(0.2)
Gain/loss on convertible senior notes
— (5.1)— 
Miscellaneous permanent items(2.4)(0.8)(1.0)
Total provision for income taxes
(11.1)%(3.4)%(1.4)%
Schedule of Deferred Tax Assets and Liabilities
The components of the Company's deferred tax assets and liabilities as of December 31, 2024 and 2023 were as follows:
Year Ended December 31,
20242023
(in thousands)
Deferred tax assets:
Net operating loss carryforwards$442,764 $390,405 
Tax credit carryforwards74,866 65,390 
Capitalized research and development expenditures109,623 71,617 
Operating lease liabilities43,135 36,609 
Business interest carryforwards— 1,244 
Stock-based compensation42,101 35,786 
Accrued expenses and reserves5,812 4,650 
Capitalized contract expenditures8,664 32,425 
Other1,542 2,235 
Gross deferred tax assets728,507 640,361 
Valuation allowance(630,590)(552,165)
Total deferred tax assets$97,917 $88,196 
Deferred tax liabilities:
Right-of-use assets(40,579)(33,337)
Deferred commissions(42,483)(32,807)
Capitalized internal-use software(4,570)(3,909)
Depreciation and amortization(21,849)(25,045)
Other(38)(57)
Total deferred tax liabilities$(109,519)$(95,155)
Net deferred tax liabilities
$(11,602)$(6,959)
Schedule of Reconciliation of Gross Unrecognized Tax Benefits
A reconciliation of the beginning and ending amount of the Company's total gross unrecognized tax benefits was as follows:
Year Ended December 31,
202420232022
(in thousands)
Balance as of the beginning of the period$29,039 $23,940 $12,590 
Increases for tax positions related to the prior year268 590 5,753 
Decreases for tax positions related to the prior year(1,232)(243)— 
Additions for tax positions related to the current year4,939 4,752 5,597 
Balance as of the end of the period$33,014 $29,039 $23,940